Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.41 |
| ▸ | NPY1R | P25929 | 5/20 | 0.41 |
| ▸ | NPY2R | P49146 | 4/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.36 |
| ▸ | TFPI | P10646 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31024637 | 0.93 | KEAP1 (0.44) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL7306013 | 0.91 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30797917 | 0.91 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31410680 | 0.90 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL29631906 | 0.90 | KEAP1 (0.52) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL30186441 | 0.90 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL30070766 | 0.88 | KEAP1 (0.37) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL30774293 | 0.88 | EPHX2 (0.38) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29375093 | 0.88 | TFPI (0.40) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL29536042 | 0.88 | GNPAT (0.44) | NPY4RNPY1RNPY2RNPY5RKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852337-A | Antitumor drug and preparation method thereof | 广西中医药大学 | 2024-10-29 | — | — | CN | claimed |
| US-11718687-B2 | Biomoletron for regulation stem cell differentiation | SOGANGN UNIVERSITY RESEARCH FOUNDATION (KR) | 2023-08-08 | — | — | US | claimed |
| CN-115466314-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-RGDV, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | claimed |
| EP-4665295-A1 | MODIFIED CROSSLINKED POLYMERS | Lifesprout, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4665784-A1 | COLLAGEN-HYDROGEL COMPOSITE | Lifesprout, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| CN-119462820-A | Carboline hexahydropyrazine-1, 4-diketone-3-acetyl-Gly-Gly as well as preparation and application thereof | 首都医科大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119390755-A | Carboline hexahydropyrazine-1, 4-diketone-3-acetyl-Val-Val, preparation and application thereof | 首都医科大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-118846107-A | Application of RGDV peptide modified genistein in preparation of medicines for treating lung cancer | 广西中医药大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852337-A | Antitumor drug and preparation method thereof | 广西中医药大学 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024172909-A9 | COLLAGEN-HYDROGEL COMPOSITE | LIFESPROUT, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | disclosed |
| WO-2023191209-A1 | MICELLE INCLUDING HYDROPHILIC PEPTIDE AND USE THEREOF | 주식회사 퓨전바이오텍 | 2023-10-05 | — | — | WO | disclosed |
| EP-4232060-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | The Regents Of The University Of Michigan (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-112225779-B | Arg(NO 2 ) -Gly-Asp-Val-gemcitabine, synthesis, anti-tumor activity and application thereof | 北京恒润泰生医药科技有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-115466314-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-RGDV, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-115466314-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-RGDV, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | disclosed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | disclosed |
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022087058-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-04-28 | — | — | WO | disclosed |